Abstract:Objective To study the effects of (-)-gossypol (LG) combined with docetaxel (DOC) for lung cancer by in vivo and in vitro experiments.Methods The inhibition rate of LG (3 and 5 μmol/L) and DOC (0.1 and 1.0 nmol/L) on proliferation of lung cancer cells (A549,A549/DDP and A549/T) was evaluated using methyl thiazolyl tetrazolium (MTT) method,and the cell apoptosis was measured by flow cytometry.C57 BL/6J mice xenograft models were established with Lewis cells.Fifteen mice were randomly divided into 7 groups,including DOC (1 and 2 mg/kg),LG (3 and 5 mg/kg),combined therapy groups (3 mg/kg LG + 1 mg/kg DOC,5 mg/kg LG + 2 mg/kg DOC) and control group,The therapeutic effects were observed.Results In the low dose combination group,the proliferation inhibition rate of lung cancer cells (A549,A549/DDP and A549/T) was (67.3 ± 3.1) ％,(64.8 ± 2.8) ％ and (54.1 ± 3.3) ％,and apoptosis rate was (50.2 ± 1.8) ％,(52.3 ± 1.5) ％ and (42.8 ± 2.4) ％,respectively.In the high dose combination group,the proliferation inhibition rate was (71.8 ± 1.9)％,(72.4±2.1)％ and (60.7 ±2.6)％,and apoptosis rate was (53.2 ± 1.8)％,(55.1 ± 1.9)％ and (46.7 ± 2.6)％,respectively.The proliferation inhibition rate and the apoptosis ratio in combination group were significantly increased (P ＜ 0.05),and CI was less than 0.5 (interpretation strong synergism).In the low and high dose combination group,the tumor inhibition rate was 49.23％ and 66.87％ respectively,which was higher than in the DOC therapy group significantly.Conclusion Combination of LG and DOC has synergistic effect on inhibition of tumor proliferation and apoptosis induction of lung cancer cells,and has favorable effect on surmounting drug resistance of lung cancer,could inhibit mice xenograft tumor of Lewis lung cancer significantly and exert more significant effect than used alone.

Valproic Acid Enhances the Anti-tumor Effect of (-)-gossypol to Burkitt Lymphoma Namalwa Cells.

Valproic acid synergistically enhances the cytotoxicity of gossypol in DU145 prostate cancer cells: an iTRTAQ-based quantitative proteomic analysis.

Synergistic cytotoxicity of Bcl-xL inhibitor, gossypol and chemotherapeutic agents in non-Hodgkin’s lymphoma cells

Valproic Acid Combined with Zoledronate Enhance Γδ T Cell-Mediated Cytotoxicity Against Osteosarcoma Cells Via the Accumulation of Mevalonate Pathway Intermediates.

Natural Bcl-2 inhibitor (−)– gossypol induces protective autophagy via reactive oxygen species–high mobility group box 1 pathway in Burkitt lymphoma

The BH3-mimetic Gossypol and Noncytotoxic Doses of Valproic Acid Induce Apoptosis by Suppressing Cyclin-A2/akt/foxo3a Signaling

Mechanism of(-)-gossypol down-regulating B lymphocyte stimulator expression in Namalwa cells via autophagy

Synergistic/additive interaction of valproic acid with bortezomib on proliferation and apoptosis of acute myeloid leukemia cells.

Sodium Valproate Synergizes Adriamycin to Inhibit Proliferation and Induce Apoptosis in Myelodysplastic Syndrome Cell Line

Effect of Valproic Acid on the Expression of P27Kip1 and P170 and Drug Resistance of HL-60/HT Cells

Synergistic Effect of Bortezomib and Valproic Acid Treatment on the Proliferation and Apoptosis of Acute Myeloid Leukemia and Myelodysplastic Syndrome Cells

A novel valproic acid prodrug as an anticancer agent that enhances doxorubicin anticancer activity and protects normal cells against its toxicity in vitro and in vivo

Histone deacetylase inhibitor potentiated the ability of MTOR inhibitor to induce autophagic cell death in Burkitt leukemia/lymphoma

Combination of (-)-gossypol and docetaxel for lung cancer

Gossypol with Hydrophobic Linear Esters Exhibits Enhanced Antitumor Activity As an Inhibitor of Antiapoptotic Proteins.

A novel bioavailable BH3 mimetic efficiently inhibits colon cancer via cascade effects of mitochondria.

Natural BH3 Mimetic (-)-gossypol Chemosensitizes Human Prostate Cancer Via Bcl-xL Inhibition Accompanied by Increase of Puma and Noxa

Anticancer Effects of Valproic Acid on Oral Squamous Cell Carcinoma Via Sumoylation in Vivo and in Vitro

Synergistic Anti-Proliferative Effects of Gambogic Acid with Docetaxel in Gastrointestinal Cancer Cell Lines

In Vitro Effects of the BH3 Mimetic, (−)-Gossypol, on Head and Neck Squamous Cell Carcinoma Cells

Valproic Acid Exhibits Biphasic Effects on Apoptotic Cell Death of Activated Lymphocytes Through Differential Modulation of Multiple Signaling Pathways